{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:25:35Z","timestamp":1769113535955,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bmc.2021.116414","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T11:28:36Z","timestamp":1631878116000},"page":"116414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors"],"prefix":"10.1016","volume":"48","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexej","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem","family":"Prakash Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Ho","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangkai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Hsiung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Cocklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bmc.2021.116414_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","article-title":"Antivirals: past, present and future","volume":"85","author":"De Clercq","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.bmc.2021.116414_b0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","article-title":"Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments","volume":"98","author":"Men\u00e9ndez-Arias","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2021.116414_b0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fimmu.2013.00337","article-title":"Eradication of HIV and Cure of AIDS, Now and How?","volume":"4","author":"Zhang","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.bmc.2021.116414_b0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/13543776.2018.1438410","article-title":"Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014\u20132017)","volume":"28","author":"Zuo","year":"2018","journal-title":"Expert Opin Ther Pat"},{"issue":"17","key":"10.1016\/j.bmc.2021.116414_b0025","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1128\/JVI.00340-15","article-title":"HIV-1 resistance to the capsid-targeting inhibitor PF74 results in altered dependence on host factors required for virus nuclear entry","volume":"89","author":"Zhou","year":"2015","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.bmc.2021.116414_b0030","doi-asserted-by":"crossref","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 assembly, budding, and maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"6243","key":"10.1016\/j.bmc.2021.116414_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.aaa5936","article-title":"X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability","volume":"349","author":"Gres","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bmc.2021.116414_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-016-0262-0","article-title":"HIV-1 capsid is involved in post-nuclear entry steps","volume":"13","author":"Chen","year":"2016","journal-title":"Retrovirology"},{"issue":"3","key":"10.1016\/j.bmc.2021.116414_b0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1570162X14999160224103555","article-title":"HIV-1 capsid inhibitors as antiretroviral agents","volume":"14","author":"Thenin-Houssier","year":"2016","journal-title":"Curr HIV Res"},{"issue":"6","key":"10.1016\/j.bmc.2021.116414_b0050","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","article-title":"The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells","volume":"39","author":"Lahaye","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bmc.2021.116414_b0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.tim.2017.04.004","article-title":"Capsid-dependent host factors in HIV-1 infection","volume":"25","author":"Yamashita","year":"2017","journal-title":"Trends Microbiol"},{"issue":"7476","key":"10.1016\/j.bmc.2021.116414_b0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature12769","article-title":"HIV-1 evades innate immune recognition through specific cofactor recruitment","volume":"503","author":"Rasaiyaah","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bmc.2021.116414_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02155-16","article-title":"Inhibition of HIV-1 maturation via small-molecule targeting of the amino-terminal domain in the viral capsid protein","volume":"91","author":"Wang","year":"2017","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.bmc.2021.116414_b0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: the multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.bmc.2021.116414_b0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/138955709787847958","article-title":"Capsid (CA) Protein as a novel drug target recent progress in the research of HIV-1 CA inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2021.116414_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113380","article-title":"An insight on medicinal aspects of novel HIV-1 capsid protein","volume":"217","author":"Sun","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"14","key":"10.1016\/j.bmc.2021.116414_b0085","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4155\/fmc-2020-0084","article-title":"Medicinal chemistry strategies of targeting","volume":"12","author":"Xu","year":"2020","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2021.116414_b0090","unstructured":"Xu JP, Francis AC, Meuser ME, et al. Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action. J Drug Des Res. 2018; 5 (2): 1070."},{"key":"10.1016\/j.bmc.2021.116414_b0095","doi-asserted-by":"crossref","unstructured":"Tang C, Loeliger E, Kinde I, et al. Antiviral Inhibition of the HIV-1 Capsid Protein. Journal of Molecular Biology. 2003; 327 (5): 1013-1020.","DOI":"10.1016\/S0022-2836(03)00289-4"},{"issue":"2","key":"10.1016\/j.bmc.2021.116414_b0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jmb.2007.07.070","article-title":"Structure of the antiviral assembly inhibitor CAP-1 bound to the HIV-1 CA protein","volume":"373","author":"Brian","year":"2007","journal-title":"J Mol Biol"},{"issue":"8","key":"10.1016\/j.bmc.2021.116414_b0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nsmb964","article-title":"A peptide inhibitor of HIV-1 assembly in vitro","volume":"12","author":"Sticht","year":"2005","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"10.1016\/j.bmc.2021.116414_b0110","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1128\/AAC.00985-13","article-title":"Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes","volume":"57","author":"Lamorte","year":"2013","journal-title":"Antimicrob Agents Chemothe"},{"issue":"12","key":"10.1016\/j.bmc.2021.116414_b0115","doi-asserted-by":"crossref","first-page":"e1001220","DOI":"10.1371\/journal.ppat.1001220","article-title":"HIV capsid is a tractable target for small molecule therapeutic intervention","volume":"6","author":"Blair","year":"2010","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.bmc.2021.116414_b0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cell.2007.08.018","article-title":"Structure of full-length HIV-1 CA: a model for the mature capsid lattice","volume":"131","author":"Ganser-Pornillos","year":"2007","journal-title":"Cell"},{"issue":"52","key":"10.1016\/j.bmc.2021.116414_b0125","doi-asserted-by":"crossref","first-page":"18625","DOI":"10.1073\/pnas.1419945112","article-title":"Structural basis of HIV-1 capsid recognition by PF74 and CPSF6","volume":"111","author":"Bhattacharya","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"10.1016\/j.bmc.2021.116414_b0130","doi-asserted-by":"crossref","first-page":"e1004459","DOI":"10.1371\/journal.ppat.1004459","article-title":"Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly","volume":"10","author":"Price","year":"2014","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.bmc.2021.116414_b0135","first-page":"1070","article-title":"Exploring Modifications of an HIV-1 Capsid Inhibitor Design","volume":"5","author":"Jimmy","year":"2018","journal-title":"J Drug Des Res."},{"issue":"16","key":"10.1016\/j.bmc.2021.116414_b0140","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1128\/JVI.05006-11","article-title":"Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid","volume":"86","author":"Kortagere","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2021.116414_b0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejmech.2018.09.029","article-title":"Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library","volume":"158","author":"Wu","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116414_b0150","doi-asserted-by":"crossref","unstructured":"Bester SM, Wei GC,Zhao HY, et al. Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science.2020; 370(6514): 360-364.","DOI":"10.1126\/science.abb4808"},{"key":"10.1016\/j.bmc.2021.116414_b0155","doi-asserted-by":"crossref","unstructured":"Jiang XY, Wu GC, Zalloum WA, et al. Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors. RSC Adv. 2019; 9 (50): 28961-28986.","DOI":"10.1039\/C9RA05869A"},{"issue":"3","key":"10.1016\/j.bmc.2021.116414_b0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.apsb.2020.07.016","article-title":"Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm Sin B."},{"key":"10.1016\/j.bmc.2021.116414_b0165","doi-asserted-by":"crossref","first-page":"112085","DOI":"10.1016\/j.ejmech.2020.112085","article-title":"Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities","volume":"190","author":"Sun","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2021.116414_b0170","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/med.21581","article-title":"Molecular design opportunities presented by solvent-exposed regions of target proteins","volume":"39","author":"Jiang","year":"2019","journal-title":"Med Res Rev"},{"issue":"2","key":"10.1016\/j.bmc.2021.116414_b0175","first-page":"1070","article-title":"Exploring Modifications of an HIV-1 Capsid Inhibitor Design, Synthesis, and Mechanism of Action","volume":"5","author":"Xu","year":"2018","journal-title":"J Drug Des Res."},{"issue":"7","key":"10.1016\/j.bmc.2021.116414_b0180","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin Chem Lett"},{"issue":"8","key":"10.1016\/j.bmc.2021.116414_b0185","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1021\/acs.jmedchem.5b01827","article-title":"Novel HIV-1 Non-nucleoside reverse transcriptase inhibitor agents: Optimization of diarylanilines with high potency against wild-type and rilpivirine-resistant E138K mutant virus","volume":"59","author":"Liu","year":"2016","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2021.116414_b0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"10.1016\/j.bmc.2021.116414_b0195","first-page":"5754","article-title":"Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies","volume":"60","author":"Kumar","year":"2020","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"10.1016\/j.bmc.2021.116414_b0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Cryst."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:58Z","timestamp":1760836498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621004223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"alternative-id":["S0968089621004223"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116414","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116414"}}